Clariant, a Swiss specialty chemicals company, announced on February 5 that it has started production of a high-throughput twin-screw compounding extruder at the Lewiston plant in Maine, USA.
With millions of dollars in investment and 40% more capacity, the facility now functions not only as an extrusion equipment but also as a material handling, weighing station, maintenance area and additional water cooling production. The upgrade allowed the Lewiston plant to operate more rapidly Production of larger quantities of MEVOPUR pre-pigmented medical plastic compounds, increasing production from 6,000 pounds to 12,000 pounds or more.
The Lewiston plant is one of three global manufacturing sites that designs and operates medical device and pharmaceutical packaging materials and two other facilities in Malmö, Sweden, and Singapore, all certified to EN ISO 13485 and using the same proven Of the raw material composition and process so that the same product can be produced at either location Raw materials are submitted in accordance with the general requirements for the declaration of equipment and pharmaceuticals and the recently published standards of USP 661.1, ICHQ3D and the European Pharmacopoeia 3.1 that cover the requirements for pharmaceutical packaging and conveying equipment Pre-test.